Louisiana Reaches ‘Netflix-Model’ Deal to Tackle Hepatitis C

June 26, 2019

(ABC News) – For years, Louisiana offered hepatitis C treatment to only the most severe cases in its Medicaid program and prisons, unable to afford broader access to the extremely high-priced medications. That will change in July, when the state begins a first-in-the-nation treatment model it says can cure tens of thousands who have the infectious, liver-damaging disease. Louisiana’s health department announced Wednesday what it called a “subscription model” deal with Gilead Sciences subsidiary Asegua Therapeutics.

Recommended Reading